These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 30320903)
1. Inhibition of extracellular signal-regulated kinase potentiates the apoptotic and antimetastatic effects of cyclin-dependent kinase inhibitors on metastatic DU145 and PC3 prostate cancer cells. Rencüzoğullari Ö; Arısan ED; Obakan Yerlikaya P; Çoker Gürkan A; Keskin B; Palavan Ünsal N J Cell Biochem; 2019 Apr; 120(4):5558-5569. PubMed ID: 30320903 [TBL] [Abstract][Full Text] [Related]
2. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells. Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543 [TBL] [Abstract][Full Text] [Related]
3. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells. Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells. Coker-Gurkan A; Arisan ED; Obakan P; Guvenir E; Unsal NP Exp Cell Res; 2014 Oct; 328(1):87-98. PubMed ID: 25088259 [TBL] [Abstract][Full Text] [Related]
5. Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines. Dizeyi N; Hedlund P; Bjartell A; Tinzl M; Austild-Taskén K; Abrahamsson PA Urol Oncol; 2011; 29(4):436-45. PubMed ID: 19926313 [TBL] [Abstract][Full Text] [Related]
6. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis. Tyagi A; Agarwal R; Agarwal C Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755 [TBL] [Abstract][Full Text] [Related]
7. Sinodielide A exerts thermosensitizing effects and induces apoptosis and G2/M cell cycle arrest in DU145 human prostate cancer cells via the Ras/Raf/MAPK and PI3K/Akt signaling pathways. Hatashita M; Taniguchi M; Baba K; Koshiba K; Sato T; Jujo Y; Suzuki R; Hayashi S Int J Mol Med; 2014 Feb; 33(2):406-14. PubMed ID: 24285252 [TBL] [Abstract][Full Text] [Related]
9. Sulindac independently modulates extracellular signal-regulated kinase 1/2 and cyclic GMP-dependent protein kinase signaling pathways. Rice PL; Peters SL; Beard KS; Ahnen DJ Mol Cancer Ther; 2006 Mar; 5(3):746-54. PubMed ID: 16546990 [TBL] [Abstract][Full Text] [Related]
10. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway. Whittaker SR; Walton MI; Garrett MD; Workman P Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633 [TBL] [Abstract][Full Text] [Related]
11. The lethal effects of pharmacological cyclin-dependent kinase inhibitors in human leukemia cells proceed through a phosphatidylinositol 3-kinase/Akt-dependent process. Yu C; Rahmani M; Dai Y; Conrad D; Krystal G; Dent P; Grant S Cancer Res; 2003 Apr; 63(8):1822-33. PubMed ID: 12702569 [TBL] [Abstract][Full Text] [Related]
12. Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway. Cusimano A; Foderà D; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G; Cervello M Cancer Biol Ther; 2007 Sep; 6(9):1461-8. PubMed ID: 18424914 [TBL] [Abstract][Full Text] [Related]
13. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53. Lee SY; Shin SJ; Kim HS Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357 [TBL] [Abstract][Full Text] [Related]
14. Differential effects of all-trans-retinoic acid (RA) on Erk1/2 phosphorylation and cAMP accumulation in normal and malignant human prostate epithelial cells: Erk1/2 inhibition restores RA-induced decrease of cell growth in malignant prostate cells. Pasquali D; Chieffi P; Deery WJ; Nicoletti G; Bellastella A; Sinisi AA Eur J Endocrinol; 2005 Apr; 152(4):663-9. PubMed ID: 15817924 [TBL] [Abstract][Full Text] [Related]
15. Porphyromonas gingivalis-related cardiac cell apoptosis was majorly co-activated by p38 and extracellular signal-regulated kinase pathways. Lee SD; Wu CC; Kuo WW; Lin JA; Hwang JM; Lu MC; Chen LM; Hsu HH; Wang CK; Chang SH; Huang CY J Periodontal Res; 2006 Feb; 41(1):39-46. PubMed ID: 16409254 [TBL] [Abstract][Full Text] [Related]
16. Pro- and anti-apoptotic roles of c-Jun N-terminal kinase (JNK) in ethanol and acetaldehyde exposed rat hepatocytes. Lee YJ; Shukla SD Eur J Pharmacol; 2005 Jan; 508(1-3):31-45. PubMed ID: 15680252 [TBL] [Abstract][Full Text] [Related]
17. Activation of ERK1/2 by NADPH oxidase-originated reactive oxygen species mediates uric acid-induced mesangial cell proliferation. Zhuang Y; Feng Q; Ding G; Zhao M; Che R; Bai M; Bao H; Zhang A; Huang S Am J Physiol Renal Physiol; 2014 Aug; 307(4):F396-406. PubMed ID: 24573389 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the ERK1/2-ubiquitous calpains pathway attenuates experimental pulmonary fibrosis in vivo and in vitro. Zou M; Zhang G; Zou J; Liu Y; Liu B; Hu X; Cheng Z Exp Cell Res; 2020 Jun; 391(1):111886. PubMed ID: 32017927 [TBL] [Abstract][Full Text] [Related]
19. Capsular Polysaccharide of Jiang Z; Song F; Li Y; Xue D; Zhao N; Zhang J; Deng G; Li M; Liu X; Wang Y Oxid Med Cell Longev; 2017; 2017():6175841. PubMed ID: 28367270 [TBL] [Abstract][Full Text] [Related]
20. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]